Pharma’s Productivity Problem: Finding More Blockbuster Drugs
Xconomy
AUGUST 16, 2016
A recent Silicon Valley Bank report noted that large corporations have dramatically increased pre-clinical acquisitions in the last three years under the pressure of limited supply and competition from IPOs. Yet despite relative plenty in the bio-venture community, pharma suffers from a shortage of drug candidates.
Let's personalize your content